HTT and Huntington disease: In animal models of Huntington’s disease, intravenous injection of a novel AAV encoding an artificial miR that targets the huntingtin (HTT) gene yielded extensive knockdown of HTT across multiple brain regions with the highest transduction observed in the striatum (199).